Page last updated: 2024-09-03

f-chemotactic peptide and piroxicam

f-chemotactic peptide has been researched along with piroxicam in 1 studies

Compound Research Comparison

Studies
(f-chemotactic peptide)
Trials
(f-chemotactic peptide)
Recent Studies (post-2010)
(f-chemotactic peptide)
Studies
(piroxicam)
Trials
(piroxicam)
Recent Studies (post-2010) (piroxicam)
79043,084796704

Protein Interaction Comparison

ProteinTaxonomyf-chemotactic peptide (IC50)piroxicam (IC50)
Prostaglandin G/H synthase 1Homo sapiens (human)1.3043
Prostaglandin G/H synthase 2 Rattus norvegicus (Norway rat)0.1
Prostaglandin G/H synthase 1 Rattus norvegicus (Norway rat)0.1

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bylund, J; Dahlgren, C; Fu, H; Karlsson, J; Stenfeldt, AL; Wennerås, C1

Other Studies

1 other study(ies) available for f-chemotactic peptide and piroxicam

ArticleYear
The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1.
    Biochemical pharmacology, 2007, Oct-01, Volume: 74, Issue:7

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Humans; Ligands; Neutrophils; Oligopeptides; Piroxicam; Protein Binding; Receptors, Formyl Peptide; Receptors, Lipoxin; Superoxides

2007